To that end, it was recently reported that a naturally occurring polymorphism of Ncf1 (an NADPH oxidase subunit; QTL Cia 14) regulates arthritis severity [19] and is currently being commercially exploited in a drug discovery programme. The gene discussed is NCF1; the disease is arthritic joint disease.